Picture of Inogen logo

INGN — Inogen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Inogen Inc expected to post a loss of 73  cents a share - Earnings Preview

* Inogen Inc  INGN.OQ   INGN.O  is expected to show a rise
in
quarterly revenue when it reports  results on February 24. 
    * The Goleta California-based  company is expected to report
 a
2.7% increase in revenue to $75.98 million from $73.98 million a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Inogen Inc is for a
loss
of 73 cents per share. For the same quarter last year, the
company reported a loss of 23 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Inogen Inc
is
$45​, about 36.6% above​ its last closing price of $28.54. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.31       -0.26      0.53      Beat    303.8
 Jun. 30 2021  -0.10       -0.11      0.22      Beat    300
 Mar. 31 2021  -0.26       -0.27      -0.03     Beat    88.8​
 Dec. 31 2020  -0.26       -0.26      -0.23     Beat    12.1
 ​​Sep.        0.00        -0.02      -0.08     Missed  -290.2
 30 2020                                                
 Jun. 30 2020  -0.05       -0.08      0.12      Beat    256.5​
 Mar. 31 2020  -0.11       -0.11      -0.07     Beat    36.8
 Dec. 31 2019  0.11        0.10       -0.06     Missed  -158.1
 This summary was machine generated February 23 at 03:03 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on Inogen

See all news